Výsledky vyhledávání - Fabrizio Giordanetto
- Zobrazuji výsledky 1 - 11 z 11
-
1
-
2
Targeting HSP70 for Cancer Therapy Autor Lorenzo Galluzzi, Fabrizio Giordanetto, Guido Kroemer
Vydáno 2009Artigo -
3
-
4
Intramolecular Hydrogen Bond Expectations in Medicinal Chemistry Autor Fabrizio Giordanetto, Christian Tyrchan, Johan Ulander
Vydáno 2017Editorial -
5
-
6
Discovery and Validation of the Binding Poses of Allosteric Fragment Hits to Protein Tyrosine Phosphatase 1b: From Molecular Dynamics Simulations to X-ray Crystallography Autor Jack B. Greisman, Lindsay Willmore, Christine Y. Yeh, Fabrizio Giordanetto, Sahar Shahamadtar, Hunter Nisonoff, Paul Maragakis, David E. Shaw
Vydáno 2023Carta -
7
-
8
Structural basis of AMPK regulation by small molecule activators Autor Bing Xiao, Matthew J. Sanders, David Carmena, Nicola J. Bright, L.F. Haire, E. Underwood, Bhakti Patel, Richard Heath, P.A. Walker, Stefan Hallén, Fabrizio Giordanetto, Stephen R. Martin, David Carling, S.J. Gamblin
Vydáno 2013Artigo -
9
Impact of Stereospecific Intramolecular Hydrogen Bonding on Cell Permeability and Physicochemical Properties Autor Björn Over, Patrick McCarren, Per Artursson, Michael A. Foley, Fabrizio Giordanetto, Gunnar Grönberg, Constanze Hilgendorf, Maurice D. Lee, Pär Matsson, Giovanni Muncipinto, Mélanie Pellisson, Matthew W. D. Perry, Richard Svensson, Jeremy R. Duvall, Jan Kihlberg
Vydáno 2014Artigo -
10
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2 Autor Heike Schönherr, Pelin Ayaz, Alexander M. Taylor, Jessica B. Casaletto, B. Barry Touré, Demetri T. Moustakas, Brandi M. Hudson, Roberto Valverde, Songping Zhao, Patrick J. O’Hearn, Lindsey Foster, Dina A. Sharon, Samuel E. Garfinkle, Fabrizio Giordanetto, André Lescarbeau, Ravi Kurukulasuriya, Nastaran Gerami-Moayed, Dejan Maglic, Kamil Bruderek, Gaauri Naik, Hakan Günaydin, Mary M. Mader, Alessandro A. Boezio, Thomas H. McLean, Rongfeng Chen, Yanxia Wang, David E. Shaw, James Watters, Donald A. Bergstrom
Vydáno 2024Artigo -
11
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia Autor Andreas Varkaris, Ermira Pazolli, Hakan Günaydin, Qi Wang, Levi Pierce, Alessandro A. Boezio, Artemisa Bulku, Lucian DiPietro, Cary Fridrich, Adam Frost, Fabrizio Giordanetto, Erika Hamilton, Katherine Harris, Michael Holliday, Tamieka L. Hunter, Amanda Iskandar, Yongli Ji, Alexandre Larivée, Jonathan R. LaRochelle, André Lescarbeau, Fabien Llambi, Brenda Lormil, Mary M. Mader, Brenton G. Mar, Iain Martin, Thomas H. McLean, Klaus Michelsen, Yakov Pechersky, Erika Puente-Poushnejad, Kevin Raynor, Dipali Rogala, Ramin Samadani, Alison M. Schram, Kelley Shortsleeves, Sweta Swaminathan, Shahein Tajmir, Gege Tan, Yong Tang, Roberto Valverde, Bryan Wehrenberg, Jeremy Wilbur, Bret R. Williams, Hongtao Zeng, Hanmo Zhang, W. Patrick Walters, Beni B. Wolf, David E. Shaw, Donald A. Bergstrom, James Watters, James S. Fraser, Pascal D. Fortin, D. Randal Kipp
Vydáno 2023Artigo
Vyhledávací nástroje:
Související témata
Biochemistry
Chemistry
Biology
Gene
Computational biology
Enzyme
Small molecule
Drug discovery
Allosteric regulation
Cell
Cell biology
Computational chemistry
Computer science
Molecule
Organic chemistry
Pharmacology
Receptor
Cancer research
Drug
Druggability
Hydrogen bond
In silico
Intramolecular force
Kinase
Medicine
Mutant
AMP-activated protein kinase
AMPK
ATPase
Activator (genetics)